Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Ophthalmology. 2010 Feb;117(2):324-33. doi: 10.1016/j.ophtha.2009.07.006. Epub 2009 Dec 6.
Evaluation of clinical features and natural course of giant choroidal nevi (diameter >or=10 mm).
Retrospective observational case series.
We included 322 eyes of 322 patients.
Clinic-based study of tumor features, tumor outcome, and vision outcome. Kaplan-Meier analysis was used to assess time to transformation into melanoma. Cox proportional hazards regressions evaluated clinical factors predictive of nevus transformation into melanoma and nevus-related decreased vision (defined as <20/20 and unrelated to other eye pathology).
Transformation of giant choroidal nevus into melanoma and nevus-related decreased vision.
A medical record review of 4100 patients diagnosed with choroidal nevus identified 322 (8%) giant choroidal nevi. Median nevus basal diameter was 11 mm (range, 10-24). Median thickness was 1.9 mm (range, 0-4.4). Related retinal findings included drusen overlying nevus (n = 261 [81%]), subretinal fluid (n = 26 [8%]), orange pigment (n = 4 [1%]), retinal pigment epithelial (RPE) detachment (n = 6 [2%]), hyperplasia (n = 48 [15%]), fibrous metaplasia (n = 48 [15%]), atrophy (n = 63 [20%]), or trough (n = 6 [2%]). Kaplan-Meier analysis estimated transformation into melanoma in 13% at 5 years and 18% at 10 years. Multivariate analyses revealed factors predictive of transformation into melanoma including involvement or close proximity to the foveola (P = 0.017) and acoustic hollowness (P = 0.052). Nevus-related decreased vision was found in 2.2% of eyes at initial visit and 3.7% at final visit (median 41 and mean 61 months follow-up). Factors associated with nevus-related decreased vision at initial visit included subretinal fluid (P = 0.001), involvement or close proximity to foveola (P = 0.005), RPE detachment (P = 0.033), and nevus-related choroidal neovascular membrane (P = 0.044). Factors predictive of nevus-related decreased vision at final visit included involvement or close proximity to the foveola (P = 0.001) and presence of symptoms at the initial visit (P = 0.032).
Giant choroidal nevi can clinically resemble choroidal melanoma but show features of chronicity, such as overlying drusen and RPE alterations. Over time, 18% transformed into melanoma, underscoring the importance of life-long surveillance.
评估直径≥10mm 的巨大脉络膜黑色素瘤(CNV)的临床特征和自然病程。
回顾性观察性病例系列研究。
纳入 322 例 322 只眼。
对肿瘤特征、肿瘤转归和视力转归进行基于临床的研究。Kaplan-Meier 分析用于评估黑色素瘤转化为黑色素瘤的时间。Cox 比例风险回归评估了预测 CNV 向黑色素瘤和 CNV 相关视力下降(定义为<20/20 且与其他眼部病理无关)的临床因素。
巨大脉络膜黑色素瘤向黑色素瘤的转化和 CNV 相关视力下降。
对 4100 例诊断为脉络膜黑色素瘤的患者进行病历回顾,发现 322 例(8%)为巨大脉络膜黑色素瘤。平均 CNV 基底直径为 11mm(范围,10-24mm)。平均厚度为 1.9mm(范围,0-4.4mm)。相关视网膜表现包括 CNV 上有视网膜色素上皮(RPE)沉积物(n=261[81%])、脉络膜视网膜下积液(n=26[8%])、橙色色素(n=4[1%])、RPE 脱离(n=6[2%])、增生(n=48[15%])、纤维性化生(n=48[15%])、萎缩(n=63[20%])或萎缩陷凹(n=6[2%])。Kaplan-Meier 分析估计 5 年时黑色素瘤转化率为 13%,10 年时为 18%。多变量分析显示,与黄斑中心凹有关或紧邻黄斑中心凹(P=0.017)和声学空洞(P=0.052)是预测黑色素瘤转化的因素。初次就诊时,2.2%的眼出现与 CNV 相关的视力下降,最终就诊时为 3.7%(中位数随访 41 个月,平均随访 61 个月)。初次就诊时与 CNV 相关的视力下降相关的因素包括脉络膜视网膜下积液(P=0.001)、与黄斑中心凹有关或紧邻黄斑中心凹(P=0.005)、RPE 脱离(P=0.033)和 CNV 相关脉络膜新生血管膜(P=0.044)。最终就诊时与 CNV 相关的视力下降相关的因素包括与黄斑中心凹有关或紧邻黄斑中心凹(P=0.001)和初次就诊时有症状(P=0.032)。
巨大脉络膜黑色素瘤在临床上可能类似于脉络膜黑色素瘤,但具有慢性特征,如上方有 RPE 沉积物和 RPE 改变。随着时间的推移,18%的患者转化为黑色素瘤,这突出了终身监测的重要性。